EPISODE · Nov 29, 2025 · 29 MIN
Selling Smart: How to Market RUO Products Without Triggering FDA Oversight
from A Splice of Life Science Marketing · host Matt Wilkinson and Jasmine Griuia-Gray | Strivenn
Your antibody copy could land you an FDA warning letter. One wrong phrase on your website transforms a research tool into an unapproved diagnostic device in the eyes of regulators.This conversation is for marketing managers at life science tools companies who need to promote Research Use Only (RUO) products without crossing regulatory lines. Josh Levin, former FDA compliance officer and diagnostics consultant, explains exactly which words trigger investigations and how to communicate analytical performance without implying diagnostic intent. Words matter: phrases like "used in diagnosis" or "detects disease" create regulatory risk; safer language references literature findings or analytical capabilities.What you will learn:The specific RUO disclaimer language FDA requires and where it must appearRed flag phrases that imply diagnostic claims versus safe alternatives that reference published researchWhy written website copy receives more FDA scrutiny than verbal sales conversationsHow to present clinical data and analytical performance without crossing into diagnostic territoryWhat compliance language belongs in distributor agreements to prevent off-label promotionThree strategic tips for tools companies considering entry into the diagnostic spaceChapters:[0:00] Introduction and defining Research Use Only[1:26] What RUO means and how FDA determines intended use[2:29] Required RUO statement placement and formatting[3:58] What manufacturers can and cannot say about RUO products[6:35] Red flag words versus safe phrasing for website copy[9:23] Framing analytical data without implying clinical validity[12:01] Application notes and case study guardrails[13:09] How AI might change FDA compliance monitoring[14:24] Working with diagnostic and clinical lab customers[21:38] Distributor compliance and partner training[22:51] Combined-function instruments and software considerations[26:13] Three tips for tools companies entering diagnosticsKeywords: Research Use Only, RUO products, FDA compliance, life science marketing, diagnostic claims, regulatory copywriting, antibody marketing, lab developed tests, ISO 13485, clinical lab regulations, tools manufacturer compliance, FDA warning lettersReady to ensure your marketing copy stays compliant? Watch this essential conversation, subscribe for more regulatory insights, and visit strivenn.com for expert guidance on life science marketing strategy.
What this episode covers
Your antibody copy could land you an FDA warning letter. One wrong phrase on your website transforms a research tool into an unapproved diagnostic device in the eyes of regulators.This conversation is for marketing managers at life science tools companies who need to promote Research Use Only (RUO) products without crossing regulatory lines. Josh Levin, former FDA compliance officer and diagnostics consultant, explains exactly which words trigger investigations and how to communicate analytical performance without implying diagnostic intent. Words matter: phrases like "used in diagnosis" or "detects disease" create regulatory risk; safer language references literature findings or analytical capabilities.What you will learn:The specific RUO disclaimer language FDA requires and where it must appearRed flag phrases that imply diagnostic claims versus safe alternatives that reference published researchWhy written website copy receives more FDA scrutiny than verbal sales conversationsHow to present clinical data and analytical performance without crossing into diagnostic territoryWhat compliance language belongs in distributor agreements to prevent off-label promotionThree strategic tips for tools companies considering entry into the diagnostic spaceChapters:[0:00] Introduction and defining Research Use Only[1:26] What RUO means and how FDA determines intended use[2:29] Required RUO statement placement and formatting[3:58] What manufacturers can and cannot say about RUO products[6:35] Red flag words versus safe phrasing for website copy[9:23] Framing analytical data without implying clinical validity[12:01] Application notes and case study guardrails[13:09] How AI might change FDA compliance monitoring[14:24] Working with diagnostic and clinical lab customers[21:38] Distributor compliance and partner training[22:51] Combined-function instruments and software considerations[26:13] Three tips for tools companies entering diagnosticsKeywords: Research Use Only, RUO products, FDA compliance, life science marketing, diagnostic claims, regulatory copywriting, antibody marketing, lab developed tests, ISO 13485, clinical lab regulations, tools manufacturer compliance, FDA warning lettersReady to ensure your marketing copy stays compliant? Watch this essential conversation, subscribe for more regulatory insights, and visit strivenn.com for expert guidance on life science marketing strategy.
NOW PLAYING
Selling Smart: How to Market RUO Products Without Triggering FDA Oversight
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m